192 related articles for article (PubMed ID: 11888668)
1. Involvement of the mt1 melatonin receptor in human breast cancer.
Ram PT; Dai J; Yuan L; Dong C; Kiefer TL; Lai L; Hill SM
Cancer Lett; 2002 May; 179(2):141-50. PubMed ID: 11888668
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin.
Dai J; Ram PT; Yuan L; Spriggs LL; Hill SM
Mol Cell Endocrinol; 2001 May; 176(1-2):111-20. PubMed ID: 11369450
[TBL] [Abstract][Full Text] [Related]
3. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.
Moretti RM; Marelli MM; Motta M; Polizzi D; Monestiroli S; Pratesi G; Limonta P
Prostate; 2001 Mar; 46(4):327-35. PubMed ID: 11241556
[TBL] [Abstract][Full Text] [Related]
4. Melatonin and type 2 diabetes - a possible link?
Peschke E; Stumpf I; Bazwinsky I; Litvak L; Dralle H; Mühlbauer E
J Pineal Res; 2007 Apr; 42(4):350-8. PubMed ID: 17439551
[TBL] [Abstract][Full Text] [Related]
5. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity.
Missbach M; Jagher B; Sigg I; Nayeri S; Carlberg C; Wiesenberg I
J Biol Chem; 1996 Jun; 271(23):13515-22. PubMed ID: 8662835
[TBL] [Abstract][Full Text] [Related]
7. Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase.
Moretti RM; Montagnani Marelli M; Sala A; Motta M; Limonta P
Int J Cancer; 2004 Oct; 112(1):87-93. PubMed ID: 15305379
[TBL] [Abstract][Full Text] [Related]
8. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
9. Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR) alpha in breast cancer cells: identification of a novel ROR response element.
Odawara H; Iwasaki T; Horiguchi J; Rokutanda N; Hirooka K; Miyazaki W; Koibuchi Y; Shimokawa N; Iino Y; Takeyoshi I; Koibuchi N
J Biol Chem; 2009 Jun; 284(26):17711-9. PubMed ID: 19439415
[TBL] [Abstract][Full Text] [Related]
10. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines.
García-Mauriño S; Pozo D; Calvo JR; Guerrero JM
J Pineal Res; 2000 Oct; 29(3):129-37. PubMed ID: 11034109
[TBL] [Abstract][Full Text] [Related]
11. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.
León J; Casado J; Carazo A; Sanjuán L; Maté A; Muñoz de Rueda P; de la Cueva P; Quiles R; Ruíz S; Ruíz-Extremera A; Salmerón J
Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice.
Collins A; Yuan L; Kiefer TL; Cheng Q; Lai L; Hill SM
Cancer Lett; 2003 Jan; 189(1):49-57. PubMed ID: 12445677
[TBL] [Abstract][Full Text] [Related]
14. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
[TBL] [Abstract][Full Text] [Related]
15. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
[TBL] [Abstract][Full Text] [Related]
16. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats.
Ting KN; Blaylock NA; Sugden D; Delagrange P; Scalbert E; Wilson VG
Br J Pharmacol; 1999 Jun; 127(4):987-95. PubMed ID: 10433507
[TBL] [Abstract][Full Text] [Related]
17. Expression of membrane and nuclear melatonin receptors in mouse peripheral organs.
Naji L; Carrillo-Vico A; Guerrero JM; Calvo JR
Life Sci; 2004 Mar; 74(18):2227-36. PubMed ID: 14987948
[TBL] [Abstract][Full Text] [Related]
18. Melatonin receptors in human uveal melanocytes and melanoma cells.
Roberts JE; Wiechmann AF; Hu DN
J Pineal Res; 2000 Apr; 28(3):165-71. PubMed ID: 10739303
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional characterization of the mt1 melatonin receptor from rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol pathway.
Blumenau C; Berger E; Fauteck JD; Madeja M; Wittkowski W; Speckmann EJ; Musshoff U
J Pineal Res; 2001 Apr; 30(3):139-46. PubMed ID: 11316324
[TBL] [Abstract][Full Text] [Related]
20. Melatonin receptor mRNA expression in human granulosa cells.
Niles LP; Wang J; Shen L; Lobb DK; Younglai EV
Mol Cell Endocrinol; 1999 Oct; 156(1-2):107-10. PubMed ID: 10612428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
